 | • レポートコード：GIR-23F3790 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥751,680 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Drugs for Dermatophytosis Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の皮膚糸状菌症治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 皮膚糸状菌症治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・Rx、OTC アプリケーション別セグメントは次のように区分されます。 ・病院、診療所、その他 世界の皮膚糸状菌症治療薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・Novartis、Pfizer、Sanofi-Aventis、Merck、Enzon Pharmaceuticals、Bayer、Astellas Pharma、GSK、Abbott 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 皮膚糸状菌症治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：Rx、OTC - アプリケーション別分析（2017年vs2021年vs2028年）：病院、診療所、その他 - 世界の皮膚糸状菌症治療薬市場規模・予測 - 世界の皮膚糸状菌症治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Novartis、Pfizer、Sanofi-Aventis、Merck、Enzon Pharmaceuticals、Bayer、Astellas Pharma、GSK、Abbott ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：Rx、OTC ・アプリケーション別分析2017年-2028年：病院、診療所、その他 ・皮膚糸状菌症治療薬の北米市場分析 - 皮膚糸状菌症治療薬の北米市場：タイプ別市場規模2017年-2028年 - 皮膚糸状菌症治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・皮膚糸状菌症治療薬のヨーロッパ市場分析 - ：皮膚糸状菌症治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：皮膚糸状菌症治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・皮膚糸状菌症治療薬のアジア太平洋市場分析 - 皮膚糸状菌症治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 皮膚糸状菌症治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・皮膚糸状菌症治療薬の南米市場分析 - 皮膚糸状菌症治療薬の南米市場：タイプ別市場規模2017年-2028年 - 皮膚糸状菌症治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・皮膚糸状菌症治療薬の中東・アフリカ市場分析 - 皮膚糸状菌症治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 皮膚糸状菌症治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Drugs for Dermatophytosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drugs for Dermatophytosis market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Drugs for Dermatophytosis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Rx segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drugs for Dermatophytosis include Novartis, Pfizer, Sanofi-Aventis, Merck, and Enzon Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drugs for Dermatophytosis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Rx
OTC
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Drugs for Dermatophytosis market are listed below:
Novartis
Pfizer
Sanofi-Aventis
Merck
Enzon Pharmaceuticals
Bayer
Astellas Pharma
GSK
Abbott
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drugs for Dermatophytosis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drugs for Dermatophytosis, with price, sales, revenue and global market share of Drugs for Dermatophytosis from 2019 to 2022.
Chapter 3, the Drugs for Dermatophytosis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drugs for Dermatophytosis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drugs for Dermatophytosis market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs for Dermatophytosis.
Chapter 13, 14, and 15, to describe Drugs for Dermatophytosis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Drugs for Dermatophytosis Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drugs for Dermatophytosis Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Rx
1.2.3 OTC
1.3 Market Analysis by Application
1.3.1 Overview: Global Drugs for Dermatophytosis Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Drugs for Dermatophytosis Market Size & Forecast
1.4.1 Global Drugs for Dermatophytosis Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drugs for Dermatophytosis Sales in Volume (2017-2028)
1.4.3 Global Drugs for Dermatophytosis Price (2017-2028)
1.5 Global Drugs for Dermatophytosis Production Capacity Analysis
1.5.1 Global Drugs for Dermatophytosis Total Production Capacity (2017-2028)
1.5.2 Global Drugs for Dermatophytosis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs for Dermatophytosis Market Drivers
1.6.2 Drugs for Dermatophytosis Market Restraints
1.6.3 Drugs for Dermatophytosis Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Drugs for Dermatophytosis Product and Services
2.1.4 Novartis Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Drugs for Dermatophytosis Product and Services
2.2.4 Pfizer Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi-Aventis
2.3.1 Sanofi-Aventis Details
2.3.2 Sanofi-Aventis Major Business
2.3.3 Sanofi-Aventis Drugs for Dermatophytosis Product and Services
2.3.4 Sanofi-Aventis Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Drugs for Dermatophytosis Product and Services
2.4.4 Merck Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Enzon Pharmaceuticals
2.5.1 Enzon Pharmaceuticals Details
2.5.2 Enzon Pharmaceuticals Major Business
2.5.3 Enzon Pharmaceuticals Drugs for Dermatophytosis Product and Services
2.5.4 Enzon Pharmaceuticals Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business
2.6.3 Bayer Drugs for Dermatophytosis Product and Services
2.6.4 Bayer Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Astellas Pharma
2.7.1 Astellas Pharma Details
2.7.2 Astellas Pharma Major Business
2.7.3 Astellas Pharma Drugs for Dermatophytosis Product and Services
2.7.4 Astellas Pharma Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 GSK
2.8.1 GSK Details
2.8.2 GSK Major Business
2.8.3 GSK Drugs for Dermatophytosis Product and Services
2.8.4 GSK Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Drugs for Dermatophytosis Product and Services
2.9.4 Abbott Drugs for Dermatophytosis Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drugs for Dermatophytosis Breakdown Data by Manufacturer
3.1 Global Drugs for Dermatophytosis Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drugs for Dermatophytosis Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drugs for Dermatophytosis
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Dermatophytosis Manufacturer Market Share in 2021
3.4.2 Top 6 Drugs for Dermatophytosis Manufacturer Market Share in 2021
3.5 Global Drugs for Dermatophytosis Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drugs for Dermatophytosis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drugs for Dermatophytosis Market Size by Region
4.1.1 Global Drugs for Dermatophytosis Sales in Volume by Region (2017-2028)
4.1.2 Global Drugs for Dermatophytosis Revenue by Region (2017-2028)
4.2 North America Drugs for Dermatophytosis Revenue (2017-2028)
4.3 Europe Drugs for Dermatophytosis Revenue (2017-2028)
4.4 Asia-Pacific Drugs for Dermatophytosis Revenue (2017-2028)
4.5 South America Drugs for Dermatophytosis Revenue (2017-2028)
4.6 Middle East and Africa Drugs for Dermatophytosis Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drugs for Dermatophytosis Sales in Volume by Type (2017-2028)
5.2 Global Drugs for Dermatophytosis Revenue by Type (2017-2028)
5.3 Global Drugs for Dermatophytosis Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drugs for Dermatophytosis Sales in Volume by Application (2017-2028)
6.2 Global Drugs for Dermatophytosis Revenue by Application (2017-2028)
6.3 Global Drugs for Dermatophytosis Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drugs for Dermatophytosis Sales by Type (2017-2028)
7.2 North America Drugs for Dermatophytosis Sales by Application (2017-2028)
7.3 North America Drugs for Dermatophytosis Market Size by Country
7.3.1 North America Drugs for Dermatophytosis Sales in Volume by Country (2017-2028)
7.3.2 North America Drugs for Dermatophytosis Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drugs for Dermatophytosis Sales by Type (2017-2028)
8.2 Europe Drugs for Dermatophytosis Sales by Application (2017-2028)
8.3 Europe Drugs for Dermatophytosis Market Size by Country
8.3.1 Europe Drugs for Dermatophytosis Sales in Volume by Country (2017-2028)
8.3.2 Europe Drugs for Dermatophytosis Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drugs for Dermatophytosis Sales by Type (2017-2028)
9.2 Asia-Pacific Drugs for Dermatophytosis Sales by Application (2017-2028)
9.3 Asia-Pacific Drugs for Dermatophytosis Market Size by Region
9.3.1 Asia-Pacific Drugs for Dermatophytosis Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drugs for Dermatophytosis Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drugs for Dermatophytosis Sales by Type (2017-2028)
10.2 South America Drugs for Dermatophytosis Sales by Application (2017-2028)
10.3 South America Drugs for Dermatophytosis Market Size by Country
10.3.1 South America Drugs for Dermatophytosis Sales in Volume by Country (2017-2028)
10.3.2 South America Drugs for Dermatophytosis Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drugs for Dermatophytosis Sales by Type (2017-2028)
11.2 Middle East & Africa Drugs for Dermatophytosis Sales by Application (2017-2028)
11.3 Middle East & Africa Drugs for Dermatophytosis Market Size by Country
11.3.1 Middle East & Africa Drugs for Dermatophytosis Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drugs for Dermatophytosis Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drugs for Dermatophytosis and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drugs for Dermatophytosis
12.3 Drugs for Dermatophytosis Production Process
12.4 Drugs for Dermatophytosis Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drugs for Dermatophytosis Typical Distributors
13.3 Drugs for Dermatophytosis Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Drugs for Dermatophytosis Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drugs for Dermatophytosis Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Drugs for Dermatophytosis Product and Services
Table 6. Novartis Drugs for Dermatophytosis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Drugs for Dermatophytosis Product and Services
Table 10. Pfizer Drugs for Dermatophytosis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi-Aventis Major Business
Table 13. Sanofi-Aventis Drugs for Dermatophytosis Product and Services
Table 14. Sanofi-Aventis Drugs for Dermatophytosis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Drugs for Dermatophytosis Product and Services
Table 18. Merck Drugs for Dermatophytosis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Enzon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Enzon Pharmaceuticals Major Business
Table 21. Enzon Pharmaceuticals Drugs for Dermatophytosis Product and Services
Table 22. Enzon Pharmaceuticals Drugs for Dermatophytosis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bayer Basic Information, Manufacturing Base and Competitors
Table 24. Bayer Major Business
Table 25. Bayer Drugs for Dermatophytosis Product and Services
Table 26. Bayer Drugs for Dermatophytosis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Astellas Pharma Major Business
Table 29. Astellas Pharma Drugs for Dermatophytosis Product and Services
Table 30. Astellas Pharma Drugs for Dermatophytosis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. GSK Basic Information, Manufacturing Base and Competitors
Table 32. GSK Major Business
Table 33. GSK Drugs for Dermatophytosis Product and Services
Table 34. GSK Drugs for Dermatophytosis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Abbott Basic Information, Manufacturing Base and Competitors
Table 36. Abbott Major Business
Table 37. Abbott Drugs for Dermatophytosis Product and Services
Table 38. Abbott Drugs for Dermatophytosis Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Drugs for Dermatophytosis Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Drugs for Dermatophytosis Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Drugs for Dermatophytosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Drugs for Dermatophytosis Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Drugs for Dermatophytosis Production Site of Key Manufacturer
Table 44. Drugs for Dermatophytosis New Entrant and Capacity Expansion Plans
Table 45. Drugs for Dermatophytosis Mergers & Acquisitions in the Past Five Years
Table 46. Global Drugs for Dermatophytosis Sales by Region (2017-2022) & (K Units)
Table 47. Global Drugs for Dermatophytosis Sales by Region (2023-2028) & (K Units)
Table 48. Global Drugs for Dermatophytosis Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Drugs for Dermatophytosis Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Drugs for Dermatophytosis Sales by Type (2017-2022) & (K Units)
Table 51. Global Drugs for Dermatophytosis Sales by Type (2023-2028) & (K Units)
Table 52. Global Drugs for Dermatophytosis Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Drugs for Dermatophytosis Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Drugs for Dermatophytosis Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Drugs for Dermatophytosis Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Drugs for Dermatophytosis Sales by Application (2017-2022) & (K Units)
Table 57. Global Drugs for Dermatophytosis Sales by Application (2023-2028) & (K Units)
Table 58. Global Drugs for Dermatophytosis Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Drugs for Dermatophytosis Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Drugs for Dermatophytosis Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Drugs for Dermatophytosis Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Drugs for Dermatophytosis Sales by Country (2017-2022) & (K Units)
Table 63. North America Drugs for Dermatophytosis Sales by Country (2023-2028) & (K Units)
Table 64. North America Drugs for Dermatophytosis Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Drugs for Dermatophytosis Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Drugs for Dermatophytosis Sales by Type (2017-2022) & (K Units)
Table 67. North America Drugs for Dermatophytosis Sales by Type (2023-2028) & (K Units)
Table 68. North America Drugs for Dermatophytosis Sales by Application (2017-2022) & (K Units)
Table 69. North America Drugs for Dermatophytosis Sales by Application (2023-2028) & (K Units)
Table 70. Europe Drugs for Dermatophytosis Sales by Country (2017-2022) & (K Units)
Table 71. Europe Drugs for Dermatophytosis Sales by Country (2023-2028) & (K Units)
Table 72. Europe Drugs for Dermatophytosis Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Drugs for Dermatophytosis Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Drugs for Dermatophytosis Sales by Type (2017-2022) & (K Units)
Table 75. Europe Drugs for Dermatophytosis Sales by Type (2023-2028) & (K Units)
Table 76. Europe Drugs for Dermatophytosis Sales by Application (2017-2022) & (K Units)
Table 77. Europe Drugs for Dermatophytosis Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Drugs for Dermatophytosis Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Drugs for Dermatophytosis Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Drugs for Dermatophytosis Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Drugs for Dermatophytosis Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Drugs for Dermatophytosis Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Drugs for Dermatophytosis Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Drugs for Dermatophytosis Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Drugs for Dermatophytosis Sales by Application (2023-2028) & (K Units)
Table 86. South America Drugs for Dermatophytosis Sales by Country (2017-2022) & (K Units)
Table 87. South America Drugs for Dermatophytosis Sales by Country (2023-2028) & (K Units)
Table 88. South America Drugs for Dermatophytosis Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Drugs for Dermatophytosis Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Drugs for Dermatophytosis Sales by Type (2017-2022) & (K Units)
Table 91. South America Drugs for Dermatophytosis Sales by Type (2023-2028) & (K Units)
Table 92. South America Drugs for Dermatophytosis Sales by Application (2017-2022) & (K Units)
Table 93. South America Drugs for Dermatophytosis Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Drugs for Dermatophytosis Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Drugs for Dermatophytosis Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Drugs for Dermatophytosis Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Drugs for Dermatophytosis Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Drugs for Dermatophytosis Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Drugs for Dermatophytosis Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Drugs for Dermatophytosis Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Drugs for Dermatophytosis Sales by Application (2023-2028) & (K Units)
Table 102. Drugs for Dermatophytosis Raw Material
Table 103. Key Manufacturers of Drugs for Dermatophytosis Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Drugs for Dermatophytosis Typical Distributors
Table 107. Drugs for Dermatophytosis Typical Customers
List of Figures
Figure 1. Drugs for Dermatophytosis Picture
Figure 2. Global Drugs for Dermatophytosis Revenue Market Share by Type in 2021
Figure 3. Rx
Figure 4. OTC
Figure 5. Global Drugs for Dermatophytosis Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Drugs for Dermatophytosis Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Drugs for Dermatophytosis Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Drugs for Dermatophytosis Sales (2017-2028) & (K Units)
Figure 12. Global Drugs for Dermatophytosis Price (2017-2028) & (USD/Unit)
Figure 13. Global Drugs for Dermatophytosis Production Capacity (2017-2028) & (K Units)
Figure 14. Global Drugs for Dermatophytosis Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Drugs for Dermatophytosis Market Drivers
Figure 16. Drugs for Dermatophytosis Market Restraints
Figure 17. Drugs for Dermatophytosis Market Trends
Figure 18. Global Drugs for Dermatophytosis Sales Market Share by Manufacturer in 2021
Figure 19. Global Drugs for Dermatophytosis Revenue Market Share by Manufacturer in 2021
Figure 20. Drugs for Dermatophytosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Drugs for Dermatophytosis Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Drugs for Dermatophytosis Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Drugs for Dermatophytosis Sales Market Share by Region (2017-2028)
Figure 24. Global Drugs for Dermatophytosis Revenue Market Share by Region (2017-2028)
Figure 25. North America Drugs for Dermatophytosis Revenue (2017-2028) & (USD Million)
Figure 26. Europe Drugs for Dermatophytosis Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Drugs for Dermatophytosis Revenue (2017-2028) & (USD Million)
Figure 28. South America Drugs for Dermatophytosis Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Drugs for Dermatophytosis Revenue (2017-2028) & (USD Million)
Figure 30. Global Drugs for Dermatophytosis Sales Market Share by Type (2017-2028)
Figure 31. Global Drugs for Dermatophytosis Revenue Market Share by Type (2017-2028)
Figure 32. Global Drugs for Dermatophytosis Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Drugs for Dermatophytosis Sales Market Share by Application (2017-2028)
Figure 34. Global Drugs for Dermatophytosis Revenue Market Share by Application (2017-2028)
Figure 35. Global Drugs for Dermatophytosis Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Drugs for Dermatophytosis Sales Market Share by Type (2017-2028)
Figure 37. North America Drugs for Dermatophytosis Sales Market Share by Application (2017-2028)
Figure 38. North America Drugs for Dermatophytosis Sales Market Share by Country (2017-2028)
Figure 39. North America Drugs for Dermatophytosis Revenue Market Share by Country (2017-2028)
Figure 40. United States Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Drugs for Dermatophytosis Sales Market Share by Type (2017-2028)
Figure 44. Europe Drugs for Dermatophytosis Sales Market Share by Application (2017-2028)
Figure 45. Europe Drugs for Dermatophytosis Sales Market Share by Country (2017-2028)
Figure 46. Europe Drugs for Dermatophytosis Revenue Market Share by Country (2017-2028)
Figure 47. Germany Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Drugs for Dermatophytosis Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Drugs for Dermatophytosis Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Drugs for Dermatophytosis Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Drugs for Dermatophytosis Revenue Market Share by Region (2017-2028)
Figure 56. China Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Drugs for Dermatophytosis Sales Market Share by Type (2017-2028)
Figure 63. South America Drugs for Dermatophytosis Sales Market Share by Application (2017-2028)
Figure 64. South America Drugs for Dermatophytosis Sales Market Share by Country (2017-2028)
Figure 65. South America Drugs for Dermatophytosis Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Drugs for Dermatophytosis Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Drugs for Dermatophytosis Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Drugs for Dermatophytosis Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Drugs for Dermatophytosis Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Drugs for Dermatophytosis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Drugs for Dermatophytosis in 2021
Figure 77. Manufacturing Process Analysis of Drugs for Dermatophytosis
Figure 78. Drugs for Dermatophytosis Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
• 日本語訳：皮膚糸状菌症治療薬のグローバル市場2022年
• レポートコード：GIR-23F3790 ▷ お問い合わせ（見積依頼・ご注文・質問）